Michael Powell
Director at Bicara Therapeutics Inc. (BCAX)
Michael Powell has filed 8 insider reports with the SEC since June 2021, as director at Bicara Therapeutics Inc. (BCAX), director at Galera Therapeutics, Inc. (GRTX) and director at Checkmate Pharmaceuticals, Inc. (CMPI). The latest filing, on June 10, 2026, reports grant or award at Bicara Therapeutics Inc. (BCAX).
- Filings
- 8
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Michael Powell is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $8.44 | Jun 10, 2026 | |||||
| Director | Jun 16, 2023 | ||||||
| Director | May 31, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 9, 2026BCAXSEC Form 4 filed by Director Powell MichaelForm 4Grant or award
- Jun 9, 2025BCAXSEC Form 4 filed by Director Powell MichaelForm 4Grant or award
- Jun 14, 2023GRTXSEC Form 4 filed by Powell MichaelForm 4Grant or award
- Jun 15, 2022GRTXSEC Form 4 filed by Powell MichaelForm 4Grant or award
- May 31, 2022CMPISEC Form 4 filed by Powell MichaelForm 4Sale back to the company
- Aug 9, 2021CMPISEC Form 4 filed by POWELL MICHAELForm 4Grant or award
- Jun 16, 2021CMPISEC Form 4 filed by POWELL MICHAELForm 4Grant or award
- Jun 16, 2021GRTXSEC Form 4 filed by POWELL MICHAELForm 4Grant or award
Compare Michael Powell with
- Michael Powell vs Ryan Cohlhepp1 shared
- Michael Powell vs Jennifer Larson1 shared
- Michael Powell vs Claire Mazumdar1 shared
- Michael Powell vs Ivan Hyep1 shared
- Michael Powell vs Mel Sorensen1 shared
- Michael Powell vs Kevin G Lokay1 shared
Other insiders at the same companies
- Ryan CohlheppBCAX
- Jennifer LarsonBCAX
- Ivan HyepBCAX
- Claire MazumdarBCAX
- Mel SorensenGRTX
- Kevin G LokayGRTX
- Nancy T ChangGRTX
- Lawrence M AllevaGRTX
- Joel F. SussmanGRTX
- Michael R. FriedmanGRTX
- Jeremy BenderBCAX
- Christy J. OligerBCAX
- Lara MeisnerBCAX
- Ra Capital Management, L.P.BCAX
- Christopher BowdenBCAX
- Kate HavilandBCAX
Questions about Michael Powell
- What is Michael Powell's role at Bicara Therapeutics Inc.?
- Michael Powell reports to the SEC as director at Bicara Therapeutics Inc. (BCAX), according to the latest filing on June 10, 2026. Michael Powell has also filed as director at Galera Therapeutics, Inc. (GRTX) and director at Checkmate Pharmaceuticals, Inc. (CMPI).
- Has Michael Powell bought or sold stock recently?
- No open-market purchases or sales by Michael Powell are on file. The filings report grant or award and sale back to the company.
- How do I get alerts when Michael Powell files?
- Follow Michael Powell on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Powell (SEC CIK 0001202793). Totals count each trade once, skipping amendments whose original is on file, from Jun 17, 2021 on. View on SEC EDGAR · Get this as JSON